Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Novel 5-HT1A agonist described by Asahi Chemical

April 1, 1997

Sanofi discloses agents for treating CRF-related disorders

March 27, 1997

New anxiolytics from American Home Products

March 27, 1997

U.S. patent covers Connetics TCR vaccine technology

March 26, 1997

Luvox cleared for OCD in children and adolescents

March 26, 1997

DepoTech's new formulation of morphine sulfate enters phase I

March 26, 1997

Novel antipsychotic agent reported by Asahi Chemical

March 26, 1997

ME-3167 heading for NDA submission

March 26, 1997

Antidepressant effects of NKH-477

March 26, 1997

Cysteine protease inhibitors described by Senju

March 26, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...